Opinionated, data-backed coverage across all asset classes

Biocon's chair says US generics tariff plan is a negotiation move, not a real threat. Company waits while exploring US partnerships for insulin and biologics.

One day left before recess. The CLARITY Act needs 60 votes to advance. Republicans hold 53 seats, requiring at least seven Democrats. BlackRock, Fidelity, and Goldman Sachs back the bill. Prediction markets now give it 27% odds.

Wintermute registers as an SEC broker-dealer to trade stocks, options, and crypto ETFs. The move gives the crypto market maker a regulated U.S. foothold. First equity trades are the next signal.